FOSRENOL

Fosrenol (lanthanum carbonate) is prescribed to patients with end stage renal disease to lower phosphate levels in the body. It works by inhibiting phosphate absorption, allowing it to be eliminated from the body. This is important because high phosphate levels can interfere with calcium absorption, leading to severe medical complications.

To minimize the chance of severe gastrointestinal problems, it is important to chew Fosrenol tablets thoroughly instead of swallowing them whole (refer to section 4.2). Individuals with renal insufficiency may experience low levels of calcium in their blood.

Warning: This medication can lead to severe stomach or bowel issues such as blockage, perforation, or extreme constipation. If you experience black, tarry stools, constipation, diarrhea, fever, nausea, severe vomiting (possibly with blood), or stomach cramps or pain, seek immediate medical attention.

It is recommended to take Fosrenol with, or right after a meal to reduce the likelihood of experiencing side effects like nausea and vomiting. It is important to chew the tablets thoroughly and not swallow them whole. If needed, the tablets can be crushed to make chewing easier.

Lanthanum, a type of medication known as a phosphate binder, can help prevent bone problems caused by high levels of phosphate in the blood. It works by binding to phosphorus from the foods you eat, preventing its absorption into the bloodstream.

Fosrenol, also known as Lanthanum carbonate, is a novel phosphate binder that does not contain aluminum or calcium. It has been specifically designed to manage hyperphosphatemia in individuals with end-stage renal disease (ESRD).

Lanthanum, also known as Fosrenol, effectively reduces phosphorus levels in the blood without impacting calcium levels in individuals with advanced kidney disease. However, it can be costly and must be taken alongside meals.

Lanthanum is classified as a rare earth metal due to the challenging, time-consuming, and costly mining process involved.

Lanthanum, comprising approximately 20% of mischmetal alloy, plays a crucial role in various applications. One notable use of this alloy is in the production of flints for cigarette lighters. Additionally, lanthanum is widely utilized in ‘rare earth’ compounds for carbon lighting purposes, including studio lighting and cinema projection.

Lanthanum, a chemical element, is commonly used in modern television sets, energy-saving lamps, fluorescent tubes, and optics such as lenses and radiation-absorbing glasses. It is also known for its ability to increase the resistivity and malleability of steel, as well as its use in catalysis in petroleum refineries.

In 1839, Carl Gustaf Mosander discovered the element as the oxide (lanthana) and differentiated it from cerium oxide (ceria). Its name, lanthanum, comes from the Greek word lanthanein, which means “to be concealed,” suggesting its challenging isolation. Lanthanum is found in the rare-earth minerals monazite and bastnasite.

Calcium acetate, sold under various brand names such as Eliphos, PhosLo, Phoslyra, and Calphron, is a calcium supplement prescribed to manage phosphate levels in the blood for individuals undergoing dialysis as a result of advanced kidney disease.

In both short- and long-term clinical studies, Lanthanum carbonate was found to be generally well tolerated. The most commonly reported adverse events were gastrointestinal in nature, such as nausea, vomiting, diarrhea, abdominal pain, and constipation. These adverse events occurred at a similar rate to other phosphate binders, including sevelamer.

FOSRENOL is a medication that helps lower phosphate levels in the body by creating insoluble lanthanum phosphate complexes. These complexes are not absorbed by the gastrointestinal tract, resulting in reduced absorption of phosphate from the diet. As a result, both serum phosphate and calcium phosphate product levels are decreased.

Stopping phosphate binders increases your risk of developing serious conditions like bone fractures, heart disease, and stroke.

Other phosphorus binders, such as Fosrenol, Phoslo, and Tums, function by attracting phosphorus in the food. This phosphorus then binds to the phosphorus binder and is transported through the digestive system for excretion.

The most common side effects of GI symptoms include diarrhea (24%), discolored feces (16%), and nausea (10%) (71). However, it has not been tested whether sucroferric oxyhydroxyde binds to other vitamins or minerals (19).

In order for your phosphate binder to be effective, it is important to take the correct dosage and timing. Typically, most individuals achieve their desired phosphorus levels by taking 3 to 4 tablets per day. It is recommended to take phosphate binders shortly before or directly after meals and snacks.

Phosphorus binders work by binding with ingested phosphorus in the gastrointestinal tract, forming insoluble complexes that are not absorbed, and ultimately reducing serum phosphorus levels. It is important to take them with meals for maximum effectiveness.

The absorption of other drugs, including bisphosphonates (such as alendronate), phenytoin, quinolone antibiotics (such as ciprofloxacin and levofloxacin), strontium, thyroid medications (such as levothyroxine), and tetracycline antibiotics (such as doxycycline and minocycline), can be decreased by this product.

Phosphate binders function by attaching to phosphate in food, thereby decreasing the absorption of phosphate into the bloodstream.

Phosphate binders are utilized to decrease the accumulation of phosphate and decrease serum phosphate levels in individuals with chronic kidney disease (CKD) in order to prevent the advancement of chronic kidney disease-mineral and bone disorder (CKD-MBD).

Lanthanum is classified as a phosphate binder medication.

Lanthanum carbonate, marketed as Fosrenol by Shire Pharmaceuticals, is a phosphate binder commonly used in clinical practice. It is indicated for the reduction of serum phosphate in patients with end stage renal disease.

Round ring binders hold the fewest pages and are not available in larger sizes. D-ring binders are more durable and have a higher capacity than round ring binders. Slant-ring binders hold fewer pages than D-ring binders, but are more durable.

Based on our findings, we can confidently state that calcium citrate is just as effective as aluminum-containing compounds when used as a phosphate binder.

If you have a history of stomach or bowel surgery, ulcers, or cancer, taking FOSRENOL may increase your chances of experiencing bowel blockage, bowel perforation, or severe constipation.

Possible rewritten output:

Possible side effects of taking this tablet may include gastrointestinal symptoms such as upset stomach, stomach pain, nausea, and vomiting, as well as constipation. Other potential adverse reactions may involve skin reactions such as itching and rash, or dental problems such as tooth injury while chewing the tablet. If you experience any of these symptoms or other unusual effects, please consult your healthcare provider for advice.

Warning: This medication can lead to severe stomach or bowel issues such as blockage, perforation, or extreme constipation. If you experience black, tarry stools, constipation, diarrhea, fever, nausea, severe vomiting (possibly with blood), or stomach cramps or pain, seek immediate medical attention.

Typically, phosphate binders should be consumed either 5 to 10 minutes before or right after meals and snacks. Your doctor and renal dietitian will provide specific instructions on when to take your phosphate binders and the appropriate dosage for each meal.

FOSRENOL is available in chewable tablet form for oral administration. The tablets come in three different strengths: 500 mg, 750 mg, and 1000 mg.

You may experience nausea, vomiting, stomach pain, diarrhea, or constipation. If any of these symptoms persist or worsen, please inform your doctor or pharmacist immediately.

Do not take this medication if you have any of the following health conditions: breathing problems, high calcium levels, or low calcium levels caused by kidney problems. Additionally, if you are currently taking ceftriaxone or digoxin, avoid taking this medication.

Do not take clonazepam if you have narrow-angle glaucoma, severe liver disease, or a history of allergic reaction to any benzodiazepine such as clonazepam, alprazolam, diazepam, lorazepam, Valium, Xanax, Versed, and others.

If you have a history of lung, liver, or kidney issues, experience spinal or cerebellar ataxia resulting in shaky movements and slurred speech, have struggled with alcohol or drug problems, or have recently experienced a loss, depression, or thoughts of self-harm, please seek medical attention.

Lanthanum carbonate, marketed as Fosrenol by Shire Pharmaceuticals, is a phosphate binder commonly used in clinical practice. It is indicated for the reduction of serum phosphate in patients with end stage renal disease.